AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 284: F525-F531, 2003. First published January 7, 2003; doi:10.1152/ajprenal.00256.2002
0363-6127/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/F525    most recent
00256.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Welch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Welch, W. J.
Vol. 284, Issue 3, F525-F531, March 2003

Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II

Christopher S. Wilcox and William J. Welch

Division of Nephrology and Hypertension and Center for Hypertension and Renal Disease Research, Georgetown University Medical Center, Washington, DC 20007

A TP receptor (TP-R) mimetic causes salt-sensitive hypertension and renal afferent arteriolar vasoconstriction. TP-Rs mediate effects of ANG II on renal vascular resistance and drinking. Therefore, we investigated the hypothesis that thromboxane A2 synthase (TxA2-S) and/or TP-R expression is regulated by salt and/or ANG II. Rats (n = 6) received high-salt (HS) or low-salt (LS) diets. Additional HS-diet rats received ANG II while other HS- and LS-diet rats received the AT1 receptor (AT1-R) antagonist losartan. Excretion of thromboxane B2 by conscious rats was increased with the HS diet compared with the LS diet (126 ± 10 vs. 48 ± 5 pmol/24 h, respectively; P < 0.01). The mRNA abundance for TP-Rs (relative to beta -actin) in the kidney cortex was enhanced 30% by the HS diet (P < 0.001) and was reduced 50% by the addition of ANG II (P < 0.001). However, during losartan administration, the effects of salt were reversed; mRNA more than doubled during the LS diet (P < 0.001). Similarly, the mRNA abundance for TP-Rs in the brain stem was reduced by 50% with the addition of ANG II (P < 0.001) and during losartan administration was almost doubled by the LS diet (P < 0.001). The mRNA abundance for TxA2-S in the kidney cortex also was increased many times with the HS diet (P < 0.001). In contrast, the mRNA for TxA2-S in the brain was unaffected by salt. ANG II did not affect TxA2-S at either site. During losartan administration, TxA2-S increased modestly in the brain stem with the LS diet. mRNA abundance for TP-Rs in the kidney cortex and brain stem is suppressed by ANG II acting on AT1-Rs. In the absence of AT1-Rs, expression of TP-Rs at both sites is enhanced by LS intake. In contrast, ANG II does not affect the mRNA abundance for TxA2-S. Expression of TxA2-S is enhanced by HS intake in the kidney cortex but by LS intake in the brain stem only during losartan administration. Thus TP-Rs are strongly dependent on ANG II acting on AT1-Rs, whereas TxA2-S is regulated differentially in the kidney cortex and brain stem by salt intake.

thromboxane A2; prostaglandins; angiotensin II; losartan; angiotensin receptor blocker; thromboxane prostanoid receptor


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Araujo and W. J. Welch
Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F790 - F794.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Sebekova, T. Eifert, A. Klassen, A. Heidland, and K. Amann
Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes
Diabetes, April 1, 2007; 56(4): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer
Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta
Hypertension, August 1, 2006; 48(2): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. J. Welch
Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F757 - F762.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Wang, T. Chabrashvili, and C. S. Wilcox
Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium
Circ. Res., June 11, 2004; 94(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online